Skip to main content
IC
Alembic Pharmaceuticals Limited (NSE:APLLTD)
India flag India · Delayed Price · Currency is INR
895.75
+16.15 (1.84%)
May 13, 2025, 3:30 PM IST

Alembic Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Alembic Pharmaceuticals had annual revenue of 66.72B INR with 7.12% growth. Alembic Pharmaceuticals had revenue of 17.70B in the quarter ending March 31, 2025, with 16.66% growth.

Revenue
66.72B
Revenue Growth
+7.12%
P/S Ratio
2.59
Revenue / Employee
4.49M
Employees
14,858
Market Cap
172.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202566.72B4.43B7.12%
Mar 31, 202462.29B5.76B10.19%
Mar 31, 202356.53B3.47B6.54%
Mar 31, 202253.06B-873.40M-1.62%
Mar 31, 202153.93B7.87B17.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 516.03B
Divi's Laboratories 90.78B
Cipla 267.20B
Mankind Pharma 116.41B
Apollo Hospitals Enterprise 211.46B
Zydus Lifesciences 222.47B
Aurobindo Pharma 309.22B
Alkem Laboratories 127.57B
Revenue Rankings

Alembic Pharmaceuticals News

More News